SEC Form 4 · accession 0001651844-16-000025
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Aug 10, 2016
Accepted (ET)
Aug 12, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Aug 10, 2016 | P | 500 | $2.47 | A | 2,907,550 | D | |
| COMMON STOCK | holding | — | — | — | 45,050 | I | TRUST |
Table II — derivative securities
No Table II lines on this filing.